Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali® (ribociclib) that underscore the extended efficacy beyond the duration of treatment in ...
Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologists and hematologists are contributors to groundbreaking breast cancer research studies being presented this week at the San ...